Newsroom

DUBAI, United Arab Emirates--(BUSINESS WIRE)--The Next Wave in FinTech: AI & Human Synergy Advisory Model by CUSP Wealth...

Dubaï, Émirats Arabes Unis--(BUSINESS WIRE)--CUSP Wealth, une société d’investissement réglementée par la DFSA, explique comment son modèle de conseil hybride combine l’optimisation de portefeuille pilotée par l’IA avec un accès à la demande à des conseillers financiers expérimentés — permettant ainsi un conseil patrimonial de niveau institutionnel avec des frais annuels de 0,75 %, soit une fraction des coûts traditionnels. « Personne d’autre sur le marché des Émirats arabes unis ne fait cela »...

MARSEILLE, France--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (Euronext Paris : IPH ; Nasdaq : IPHA) (« Innate » ou la « Société ») annonce aujourd’hui ses résultats financiers consolidés au 31 décembre 2025. Les comptes consolidés sont joints au présent communiqué. « L'année 2025 a été marquée par une exécution solide de l'ensemble de notre portefeuille. Avec la finalisation du design de TELLOMAK-3 et l’autorisation de la FDA, nous prévoyons d’initier l’essai confirmatoire de Phase 3 a...

MARSEILLE, France--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today reported its business update and consolidated financial results for the year ending December 31, 2025. The consolidated financial statements are attached to this press release. “2025 has been a year of strong execution across our portfolio. With the TELLOMAK-3 design finalized and FDA clearance in hand, lacutamab is planned for confirmatory Phase 3 initiati...

SAN DIEGO--(BUSINESS WIRE)--Invivoscribe, a global leader in precision diagnostics and measurable residual disease (MRD) testing, is proud to announce that its IdentiClone Dx IGH Assay has received In Vitro Diagnostic Regulation (IVDR) 2017/746 Class C certification in the European Union (EU). Commercial availability of the IVDR-certified assay is anticipated by early April 2026. The IVDR replaces the former In Vitro Diagnostics Directive (IVDD), introducing significantly more stringent require...

BARCELONA, Spain--(BUSINESS WIRE)--Hytera unveiled the PNC660 450MHz MCX Smart Device – an advanced mission-critical terminal for private 450MHz LTE and 5G networks at MWC Barcelona....

SINGAPORE--(BUSINESS WIRE)--H2O.ai, the leading open-source AI platform company, and CTC Global Singapore, a trusted technology integrator across Asia Pacific, today announced a collaboration to accelerate enterprise AI adoption across the region. The collaboration was formalized at a signing ceremony in Singapore, marking a milestone in delivering trusted, production-grade Agentic AI designed to support users in secure and regulated environments. This partnership directly addresses the evolvin...

DENVER--(BUSINESS WIRE)--Liberty Energy Inc. (NYSE: LBRT) (“Liberty”) today announced the pricing of, and that it has agreed to sell, $475.0 million aggregate principal amount of 0.00% convertible senior notes due 2032 (the “Notes”) in a private offering (the “Notes Offering”) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Liberty also granted the initial purchasers an option to purch...

OSAKA, Japan--(BUSINESS WIRE)--Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; “Ono”) today announced that Ono submitted an application for the manufacturing and marketing approval of ripretinib (DCC-2618), developed by Deciphera Pharmaceuticals, Inc. (“Deciphera”), for the indication of “gastrointestinal stromal tumor that has progressed following cancer chemotherapy.” This application is based on the results of the INVICTUS study, a global Phase 3 clinical...

BURLINGTON, Ontario--(BUSINESS WIRE)--Anaergia (TSX: ANRG; OTCQX:ANRGF) reports positive Adjusted EBITDA, 61% revenue growth and Revenue Backlog up 149% in fiscal 2025....